nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—CA4—Alzheimer's disease	0.549	1	CbGaD
Dorzolamide—CYP2C9—Donepezil—Alzheimer's disease	0.06	0.373	CbGbCtD
Dorzolamide—CYP3A4—Rivastigmine—Alzheimer's disease	0.0436	0.271	CbGbCtD
Dorzolamide—CYP3A4—Donepezil—Alzheimer's disease	0.0349	0.217	CbGbCtD
Dorzolamide—CYP3A4—Galantamine—Alzheimer's disease	0.0225	0.14	CbGbCtD
Dorzolamide—Brinzolamide—CA4—Alzheimer's disease	0.00496	1	CrCbGaD
Dorzolamide—CA14—telencephalon—Alzheimer's disease	0.00128	0.0683	CbGeAlD
Dorzolamide—CA12—forebrain—Alzheimer's disease	0.00109	0.0579	CbGeAlD
Dorzolamide—CA12—telencephalon—Alzheimer's disease	0.001	0.0533	CbGeAlD
Dorzolamide—CA1—forebrain—Alzheimer's disease	0.000862	0.0459	CbGeAlD
Dorzolamide—CA7—cerebellum—Alzheimer's disease	0.000855	0.0455	CbGeAlD
Dorzolamide—CA1—telencephalon—Alzheimer's disease	0.000792	0.0422	CbGeAlD
Dorzolamide—CA9—cerebellum—Alzheimer's disease	0.000751	0.04	CbGeAlD
Dorzolamide—CA14—cerebellum—Alzheimer's disease	0.000712	0.0379	CbGeAlD
Dorzolamide—CA7—brain—Alzheimer's disease	0.000695	0.037	CbGeAlD
Dorzolamide—CA4—forebrain—Alzheimer's disease	0.000673	0.0359	CbGeAlD
Dorzolamide—CA2—embryo—Alzheimer's disease	0.000631	0.0336	CbGeAlD
Dorzolamide—CA4—telencephalon—Alzheimer's disease	0.000619	0.033	CbGeAlD
Dorzolamide—CA12—nervous system—Alzheimer's disease	0.00059	0.0314	CbGeAlD
Dorzolamide—CA14—brain—Alzheimer's disease	0.000579	0.0308	CbGeAlD
Dorzolamide—CA12—central nervous system—Alzheimer's disease	0.000568	0.0303	CbGeAlD
Dorzolamide—CA2—forebrain—Alzheimer's disease	0.000558	0.0297	CbGeAlD
Dorzolamide—CA5B—nervous system—Alzheimer's disease	0.00053	0.0282	CbGeAlD
Dorzolamide—Bronchitis—Donepezil—Alzheimer's disease	0.000516	0.00296	CcSEcCtD
Dorzolamide—CA2—telencephalon—Alzheimer's disease	0.000513	0.0273	CbGeAlD
Dorzolamide—CA5B—central nervous system—Alzheimer's disease	0.00051	0.0272	CbGeAlD
Dorzolamide—Dysuria—Donepezil—Alzheimer's disease	0.000501	0.00288	CcSEcCtD
Dorzolamide—Arrhythmia—Galantamine—Alzheimer's disease	0.000495	0.00284	CcSEcCtD
Dorzolamide—Influenza—Memantine—Alzheimer's disease	0.000487	0.0028	CcSEcCtD
Dorzolamide—Weight decreased—Donepezil—Alzheimer's disease	0.000485	0.00279	CcSEcCtD
Dorzolamide—Hyperglycaemia—Donepezil—Alzheimer's disease	0.000484	0.00278	CcSEcCtD
Dorzolamide—Bronchospasm—Memantine—Alzheimer's disease	0.000479	0.00275	CcSEcCtD
Dorzolamide—Depression—Donepezil—Alzheimer's disease	0.000477	0.00274	CcSEcCtD
Dorzolamide—Angina pectoris—Memantine—Alzheimer's disease	0.000474	0.00273	CcSEcCtD
Dorzolamide—Tension—Galantamine—Alzheimer's disease	0.000473	0.00272	CcSEcCtD
Dorzolamide—Dysgeusia—Galantamine—Alzheimer's disease	0.000472	0.00271	CcSEcCtD
Dorzolamide—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000471	0.00271	CcSEcCtD
Dorzolamide—Myocardial infarction—Donepezil—Alzheimer's disease	0.000469	0.00269	CcSEcCtD
Dorzolamide—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000468	0.00269	CcSEcCtD
Dorzolamide—Nervousness—Galantamine—Alzheimer's disease	0.000468	0.00269	CcSEcCtD
Dorzolamide—Bronchitis—Memantine—Alzheimer's disease	0.000468	0.00269	CcSEcCtD
Dorzolamide—CA1—nervous system—Alzheimer's disease	0.000468	0.0249	CbGeAlD
Dorzolamide—Back pain—Galantamine—Alzheimer's disease	0.000466	0.00268	CcSEcCtD
Dorzolamide—Conjunctivitis—Donepezil—Alzheimer's disease	0.000465	0.00267	CcSEcCtD
Dorzolamide—Urinary tract infection—Donepezil—Alzheimer's disease	0.000465	0.00267	CcSEcCtD
Dorzolamide—Angina pectoris—Rivastigmine—Alzheimer's disease	0.000464	0.00267	CcSEcCtD
Dorzolamide—Sweating—Donepezil—Alzheimer's disease	0.000458	0.00263	CcSEcCtD
Dorzolamide—Bronchitis—Rivastigmine—Alzheimer's disease	0.000458	0.00263	CcSEcCtD
Dorzolamide—Dysuria—Memantine—Alzheimer's disease	0.000455	0.00262	CcSEcCtD
Dorzolamide—Vision blurred—Galantamine—Alzheimer's disease	0.000454	0.00261	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000452	0.0026	CcSEcCtD
Dorzolamide—CA12—brain—Alzheimer's disease	0.000451	0.024	CbGeAlD
Dorzolamide—Epistaxis—Donepezil—Alzheimer's disease	0.000451	0.00259	CcSEcCtD
Dorzolamide—CA1—central nervous system—Alzheimer's disease	0.00045	0.024	CbGeAlD
Dorzolamide—Erectile dysfunction—Memantine—Alzheimer's disease	0.000448	0.00258	CcSEcCtD
Dorzolamide—Dysuria—Rivastigmine—Alzheimer's disease	0.000445	0.00256	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000443	0.00254	CcSEcCtD
Dorzolamide—Weight decreased—Memantine—Alzheimer's disease	0.00044	0.00253	CcSEcCtD
Dorzolamide—Hyperglycaemia—Memantine—Alzheimer's disease	0.000439	0.00252	CcSEcCtD
Dorzolamide—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000439	0.00252	CcSEcCtD
Dorzolamide—Bradycardia—Donepezil—Alzheimer's disease	0.000437	0.00251	CcSEcCtD
Dorzolamide—Vertigo—Galantamine—Alzheimer's disease	0.000433	0.00249	CcSEcCtD
Dorzolamide—Depression—Memantine—Alzheimer's disease	0.000433	0.00249	CcSEcCtD
Dorzolamide—Syncope—Galantamine—Alzheimer's disease	0.000432	0.00249	CcSEcCtD
Dorzolamide—Weight decreased—Rivastigmine—Alzheimer's disease	0.000431	0.00248	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.00043	0.00247	CcSEcCtD
Dorzolamide—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00043	0.00247	CcSEcCtD
Dorzolamide—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000428	0.00246	CcSEcCtD
Dorzolamide—Hallucination—Donepezil—Alzheimer's disease	0.000427	0.00245	CcSEcCtD
Dorzolamide—Palpitations—Galantamine—Alzheimer's disease	0.000426	0.00245	CcSEcCtD
Dorzolamide—Pharyngitis—Donepezil—Alzheimer's disease	0.000426	0.00245	CcSEcCtD
Dorzolamide—Myocardial infarction—Memantine—Alzheimer's disease	0.000425	0.00245	CcSEcCtD
Dorzolamide—Loss of consciousness—Galantamine—Alzheimer's disease	0.000424	0.00244	CcSEcCtD
Dorzolamide—Depression—Rivastigmine—Alzheimer's disease	0.000423	0.00243	CcSEcCtD
Dorzolamide—Urinary tract infection—Memantine—Alzheimer's disease	0.000422	0.00243	CcSEcCtD
Dorzolamide—Conjunctivitis—Memantine—Alzheimer's disease	0.000422	0.00243	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000421	0.00242	CcSEcCtD
Dorzolamide—Cough—Galantamine—Alzheimer's disease	0.000421	0.00242	CcSEcCtD
Dorzolamide—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000419	0.00241	CcSEcCtD
Dorzolamide—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000416	0.00239	CcSEcCtD
Dorzolamide—Hypertension—Galantamine—Alzheimer's disease	0.000416	0.00239	CcSEcCtD
Dorzolamide—Visual impairment—Donepezil—Alzheimer's disease	0.000414	0.00238	CcSEcCtD
Dorzolamide—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000413	0.00237	CcSEcCtD
Dorzolamide—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000413	0.00237	CcSEcCtD
Dorzolamide—Arthralgia—Galantamine—Alzheimer's disease	0.00041	0.00236	CcSEcCtD
Dorzolamide—Chest pain—Galantamine—Alzheimer's disease	0.00041	0.00236	CcSEcCtD
Dorzolamide—Epistaxis—Memantine—Alzheimer's disease	0.000409	0.00235	CcSEcCtD
Dorzolamide—Anxiety—Galantamine—Alzheimer's disease	0.000409	0.00235	CcSEcCtD
Dorzolamide—Sinusitis—Memantine—Alzheimer's disease	0.000407	0.00234	CcSEcCtD
Dorzolamide—Sweating—Rivastigmine—Alzheimer's disease	0.000407	0.00234	CcSEcCtD
Dorzolamide—Discomfort—Galantamine—Alzheimer's disease	0.000405	0.00233	CcSEcCtD
Dorzolamide—Agranulocytosis—Memantine—Alzheimer's disease	0.000405	0.00233	CcSEcCtD
Dorzolamide—CA5B—brain—Alzheimer's disease	0.000405	0.0216	CbGeAlD
Dorzolamide—Dry mouth—Galantamine—Alzheimer's disease	0.000401	0.00231	CcSEcCtD
Dorzolamide—Epistaxis—Rivastigmine—Alzheimer's disease	0.0004	0.0023	CcSEcCtD
Dorzolamide—Tinnitus—Donepezil—Alzheimer's disease	0.0004	0.0023	CcSEcCtD
Dorzolamide—Sinusitis—Rivastigmine—Alzheimer's disease	0.000398	0.00229	CcSEcCtD
Dorzolamide—Confusional state—Galantamine—Alzheimer's disease	0.000397	0.00228	CcSEcCtD
Dorzolamide—Bradycardia—Memantine—Alzheimer's disease	0.000397	0.00228	CcSEcCtD
Dorzolamide—Bradycardia—Rivastigmine—Alzheimer's disease	0.000388	0.00223	CcSEcCtD
Dorzolamide—Hallucination—Memantine—Alzheimer's disease	0.000388	0.00223	CcSEcCtD
Dorzolamide—Shock—Galantamine—Alzheimer's disease	0.000387	0.00223	CcSEcCtD
Dorzolamide—Pharyngitis—Memantine—Alzheimer's disease	0.000387	0.00222	CcSEcCtD
Dorzolamide—Arrhythmia—Donepezil—Alzheimer's disease	0.000383	0.0022	CcSEcCtD
Dorzolamide—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00038	0.00219	CcSEcCtD
Dorzolamide—Hallucination—Rivastigmine—Alzheimer's disease	0.000379	0.00218	CcSEcCtD
Dorzolamide—Alopecia—Donepezil—Alzheimer's disease	0.000379	0.00218	CcSEcCtD
Dorzolamide—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000378	0.00217	CcSEcCtD
Dorzolamide—Visual impairment—Memantine—Alzheimer's disease	0.000375	0.00216	CcSEcCtD
Dorzolamide—Anorexia—Galantamine—Alzheimer's disease	0.000375	0.00216	CcSEcCtD
Dorzolamide—Erythema—Donepezil—Alzheimer's disease	0.000374	0.00215	CcSEcCtD
Dorzolamide—Erythema multiforme—Memantine—Alzheimer's disease	0.000368	0.00212	CcSEcCtD
Dorzolamide—Hypotension—Galantamine—Alzheimer's disease	0.000368	0.00211	CcSEcCtD
Dorzolamide—Visual impairment—Rivastigmine—Alzheimer's disease	0.000367	0.00211	CcSEcCtD
Dorzolamide—Tension—Donepezil—Alzheimer's disease	0.000367	0.00211	CcSEcCtD
Dorzolamide—Dysgeusia—Donepezil—Alzheimer's disease	0.000366	0.0021	CcSEcCtD
Dorzolamide—CA4—nervous system—Alzheimer's disease	0.000366	0.0195	CbGeAlD
Dorzolamide—Tinnitus—Memantine—Alzheimer's disease	0.000363	0.00209	CcSEcCtD
Dorzolamide—Nervousness—Donepezil—Alzheimer's disease	0.000363	0.00209	CcSEcCtD
Dorzolamide—Back pain—Donepezil—Alzheimer's disease	0.000361	0.00208	CcSEcCtD
Dorzolamide—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.00036	0.00207	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000358	0.00206	CcSEcCtD
Dorzolamide—CA1—brain—Alzheimer's disease	0.000358	0.019	CbGeAlD
Dorzolamide—Insomnia—Galantamine—Alzheimer's disease	0.000356	0.00205	CcSEcCtD
Dorzolamide—Tinnitus—Rivastigmine—Alzheimer's disease	0.000355	0.00204	CcSEcCtD
Dorzolamide—Paraesthesia—Galantamine—Alzheimer's disease	0.000353	0.00203	CcSEcCtD
Dorzolamide—Vision blurred—Donepezil—Alzheimer's disease	0.000352	0.00202	CcSEcCtD
Dorzolamide—CA4—central nervous system—Alzheimer's disease	0.000352	0.0187	CbGeAlD
Dorzolamide—Somnolence—Galantamine—Alzheimer's disease	0.00035	0.00201	CcSEcCtD
Dorzolamide—Arrhythmia—Memantine—Alzheimer's disease	0.000348	0.002	CcSEcCtD
Dorzolamide—Dyspepsia—Galantamine—Alzheimer's disease	0.000346	0.00199	CcSEcCtD
Dorzolamide—Alopecia—Memantine—Alzheimer's disease	0.000344	0.00198	CcSEcCtD
Dorzolamide—CA4—cerebellum—Alzheimer's disease	0.000344	0.0183	CbGeAlD
Dorzolamide—Decreased appetite—Galantamine—Alzheimer's disease	0.000342	0.00197	CcSEcCtD
Dorzolamide—Arrhythmia—Rivastigmine—Alzheimer's disease	0.00034	0.00196	CcSEcCtD
Dorzolamide—Fatigue—Galantamine—Alzheimer's disease	0.000339	0.00195	CcSEcCtD
Dorzolamide—Alopecia—Rivastigmine—Alzheimer's disease	0.000337	0.00194	CcSEcCtD
Dorzolamide—Vertigo—Donepezil—Alzheimer's disease	0.000336	0.00193	CcSEcCtD
Dorzolamide—Syncope—Donepezil—Alzheimer's disease	0.000335	0.00193	CcSEcCtD
Dorzolamide—Tension—Memantine—Alzheimer's disease	0.000333	0.00191	CcSEcCtD
Dorzolamide—Dysgeusia—Memantine—Alzheimer's disease	0.000332	0.00191	CcSEcCtD
Dorzolamide—Erythema—Rivastigmine—Alzheimer's disease	0.000332	0.00191	CcSEcCtD
Dorzolamide—Nervousness—Memantine—Alzheimer's disease	0.000329	0.00189	CcSEcCtD
Dorzolamide—Loss of consciousness—Donepezil—Alzheimer's disease	0.000328	0.00189	CcSEcCtD
Dorzolamide—Back pain—Memantine—Alzheimer's disease	0.000328	0.00189	CcSEcCtD
Dorzolamide—Cough—Donepezil—Alzheimer's disease	0.000326	0.00187	CcSEcCtD
Dorzolamide—Tension—Rivastigmine—Alzheimer's disease	0.000326	0.00187	CcSEcCtD
Dorzolamide—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000325	0.00187	CcSEcCtD
Dorzolamide—Feeling abnormal—Galantamine—Alzheimer's disease	0.000324	0.00186	CcSEcCtD
Dorzolamide—Hypertension—Donepezil—Alzheimer's disease	0.000322	0.00185	CcSEcCtD
Dorzolamide—Nervousness—Rivastigmine—Alzheimer's disease	0.000322	0.00185	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000322	0.00185	CcSEcCtD
Dorzolamide—Back pain—Rivastigmine—Alzheimer's disease	0.000321	0.00185	CcSEcCtD
Dorzolamide—Vision blurred—Memantine—Alzheimer's disease	0.00032	0.00184	CcSEcCtD
Dorzolamide—Arthralgia—Donepezil—Alzheimer's disease	0.000318	0.00183	CcSEcCtD
Dorzolamide—Chest pain—Donepezil—Alzheimer's disease	0.000318	0.00183	CcSEcCtD
Dorzolamide—Anxiety—Donepezil—Alzheimer's disease	0.000317	0.00182	CcSEcCtD
Dorzolamide—Discomfort—Donepezil—Alzheimer's disease	0.000314	0.00181	CcSEcCtD
Dorzolamide—Vision blurred—Rivastigmine—Alzheimer's disease	0.000313	0.0018	CcSEcCtD
Dorzolamide—Dry mouth—Donepezil—Alzheimer's disease	0.000311	0.00179	CcSEcCtD
Dorzolamide—Abdominal pain—Galantamine—Alzheimer's disease	0.000311	0.00179	CcSEcCtD
Dorzolamide—Body temperature increased—Galantamine—Alzheimer's disease	0.000311	0.00179	CcSEcCtD
Dorzolamide—Confusional state—Donepezil—Alzheimer's disease	0.000307	0.00177	CcSEcCtD
Dorzolamide—Oedema—Donepezil—Alzheimer's disease	0.000305	0.00175	CcSEcCtD
Dorzolamide—Vertigo—Memantine—Alzheimer's disease	0.000305	0.00175	CcSEcCtD
Dorzolamide—Syncope—Memantine—Alzheimer's disease	0.000304	0.00175	CcSEcCtD
Dorzolamide—CA2—nervous system—Alzheimer's disease	0.000303	0.0161	CbGeAlD
Dorzolamide—Shock—Donepezil—Alzheimer's disease	0.0003	0.00172	CcSEcCtD
Dorzolamide—Palpitations—Memantine—Alzheimer's disease	0.0003	0.00172	CcSEcCtD
Dorzolamide—Vertigo—Rivastigmine—Alzheimer's disease	0.000298	0.00171	CcSEcCtD
Dorzolamide—Loss of consciousness—Memantine—Alzheimer's disease	0.000298	0.00171	CcSEcCtD
Dorzolamide—Syncope—Rivastigmine—Alzheimer's disease	0.000298	0.00171	CcSEcCtD
Dorzolamide—Cough—Memantine—Alzheimer's disease	0.000296	0.0017	CcSEcCtD
Dorzolamide—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000295	0.00169	CcSEcCtD
Dorzolamide—Palpitations—Rivastigmine—Alzheimer's disease	0.000293	0.00169	CcSEcCtD
Dorzolamide—Hypertension—Memantine—Alzheimer's disease	0.000293	0.00168	CcSEcCtD
Dorzolamide—CA2—central nervous system—Alzheimer's disease	0.000292	0.0155	CbGeAlD
Dorzolamide—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000292	0.00168	CcSEcCtD
Dorzolamide—Anorexia—Donepezil—Alzheimer's disease	0.000291	0.00167	CcSEcCtD
Dorzolamide—Hypersensitivity—Galantamine—Alzheimer's disease	0.00029	0.00167	CcSEcCtD
Dorzolamide—Cough—Rivastigmine—Alzheimer's disease	0.00029	0.00166	CcSEcCtD
Dorzolamide—Arthralgia—Memantine—Alzheimer's disease	0.000289	0.00166	CcSEcCtD
Dorzolamide—Chest pain—Memantine—Alzheimer's disease	0.000289	0.00166	CcSEcCtD
Dorzolamide—Anxiety—Memantine—Alzheimer's disease	0.000288	0.00165	CcSEcCtD
Dorzolamide—Hypertension—Rivastigmine—Alzheimer's disease	0.000286	0.00165	CcSEcCtD
Dorzolamide—Discomfort—Memantine—Alzheimer's disease	0.000285	0.00164	CcSEcCtD
Dorzolamide—CA2—cerebellum—Alzheimer's disease	0.000285	0.0152	CbGeAlD
Dorzolamide—Hypotension—Donepezil—Alzheimer's disease	0.000285	0.00164	CcSEcCtD
Dorzolamide—Chest pain—Rivastigmine—Alzheimer's disease	0.000282	0.00162	CcSEcCtD
Dorzolamide—Arthralgia—Rivastigmine—Alzheimer's disease	0.000282	0.00162	CcSEcCtD
Dorzolamide—Dry mouth—Memantine—Alzheimer's disease	0.000282	0.00162	CcSEcCtD
Dorzolamide—Asthenia—Galantamine—Alzheimer's disease	0.000282	0.00162	CcSEcCtD
Dorzolamide—Anxiety—Rivastigmine—Alzheimer's disease	0.000281	0.00162	CcSEcCtD
Dorzolamide—CA4—brain—Alzheimer's disease	0.000279	0.0149	CbGeAlD
Dorzolamide—Confusional state—Memantine—Alzheimer's disease	0.000279	0.0016	CcSEcCtD
Dorzolamide—Discomfort—Rivastigmine—Alzheimer's disease	0.000279	0.0016	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000278	0.0016	CcSEcCtD
Dorzolamide—Oedema—Memantine—Alzheimer's disease	0.000277	0.00159	CcSEcCtD
Dorzolamide—Dry mouth—Rivastigmine—Alzheimer's disease	0.000276	0.00159	CcSEcCtD
Dorzolamide—Insomnia—Donepezil—Alzheimer's disease	0.000276	0.00159	CcSEcCtD
Dorzolamide—Paraesthesia—Donepezil—Alzheimer's disease	0.000274	0.00157	CcSEcCtD
Dorzolamide—Confusional state—Rivastigmine—Alzheimer's disease	0.000273	0.00157	CcSEcCtD
Dorzolamide—Shock—Memantine—Alzheimer's disease	0.000272	0.00157	CcSEcCtD
Dorzolamide—Dyspnoea—Donepezil—Alzheimer's disease	0.000272	0.00156	CcSEcCtD
Dorzolamide—Somnolence—Donepezil—Alzheimer's disease	0.000271	0.00156	CcSEcCtD
Dorzolamide—Oedema—Rivastigmine—Alzheimer's disease	0.000271	0.00156	CcSEcCtD
Dorzolamide—Diarrhoea—Galantamine—Alzheimer's disease	0.000269	0.00155	CcSEcCtD
Dorzolamide—Dyspepsia—Donepezil—Alzheimer's disease	0.000268	0.00154	CcSEcCtD
Dorzolamide—Hyperhidrosis—Memantine—Alzheimer's disease	0.000268	0.00154	CcSEcCtD
Dorzolamide—Shock—Rivastigmine—Alzheimer's disease	0.000266	0.00153	CcSEcCtD
Dorzolamide—Decreased appetite—Donepezil—Alzheimer's disease	0.000265	0.00152	CcSEcCtD
Dorzolamide—Anorexia—Memantine—Alzheimer's disease	0.000264	0.00152	CcSEcCtD
Dorzolamide—Fatigue—Donepezil—Alzheimer's disease	0.000263	0.00151	CcSEcCtD
Dorzolamide—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000262	0.00151	CcSEcCtD
Dorzolamide—Pain—Donepezil—Alzheimer's disease	0.000261	0.0015	CcSEcCtD
Dorzolamide—Dizziness—Galantamine—Alzheimer's disease	0.00026	0.0015	CcSEcCtD
Dorzolamide—Hypotension—Memantine—Alzheimer's disease	0.000259	0.00149	CcSEcCtD
Dorzolamide—Anorexia—Rivastigmine—Alzheimer's disease	0.000258	0.00148	CcSEcCtD
Dorzolamide—Hypotension—Rivastigmine—Alzheimer's disease	0.000253	0.00145	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000252	0.00145	CcSEcCtD
Dorzolamide—Feeling abnormal—Donepezil—Alzheimer's disease	0.000251	0.00144	CcSEcCtD
Dorzolamide—Insomnia—Memantine—Alzheimer's disease	0.00025	0.00144	CcSEcCtD
Dorzolamide—Vomiting—Galantamine—Alzheimer's disease	0.00025	0.00144	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000249	0.00143	CcSEcCtD
Dorzolamide—Paraesthesia—Memantine—Alzheimer's disease	0.000249	0.00143	CcSEcCtD
Dorzolamide—Rash—Galantamine—Alzheimer's disease	0.000248	0.00143	CcSEcCtD
Dorzolamide—Dermatitis—Galantamine—Alzheimer's disease	0.000248	0.00142	CcSEcCtD
Dorzolamide—Dyspnoea—Memantine—Alzheimer's disease	0.000247	0.00142	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000247	0.00142	CcSEcCtD
Dorzolamide—Headache—Galantamine—Alzheimer's disease	0.000246	0.00142	CcSEcCtD
Dorzolamide—Somnolence—Memantine—Alzheimer's disease	0.000246	0.00141	CcSEcCtD
Dorzolamide—Insomnia—Rivastigmine—Alzheimer's disease	0.000245	0.00141	CcSEcCtD
Dorzolamide—Dyspepsia—Memantine—Alzheimer's disease	0.000244	0.0014	CcSEcCtD
Dorzolamide—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000243	0.0014	CcSEcCtD
Dorzolamide—Urticaria—Donepezil—Alzheimer's disease	0.000242	0.00139	CcSEcCtD
Dorzolamide—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000241	0.00139	CcSEcCtD
Dorzolamide—Body temperature increased—Donepezil—Alzheimer's disease	0.000241	0.00139	CcSEcCtD
Dorzolamide—Abdominal pain—Donepezil—Alzheimer's disease	0.000241	0.00139	CcSEcCtD
Dorzolamide—Somnolence—Rivastigmine—Alzheimer's disease	0.000241	0.00138	CcSEcCtD
Dorzolamide—Decreased appetite—Memantine—Alzheimer's disease	0.000241	0.00138	CcSEcCtD
Dorzolamide—Fatigue—Memantine—Alzheimer's disease	0.000239	0.00137	CcSEcCtD
Dorzolamide—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000238	0.00137	CcSEcCtD
Dorzolamide—Pain—Memantine—Alzheimer's disease	0.000237	0.00136	CcSEcCtD
Dorzolamide—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000235	0.00135	CcSEcCtD
Dorzolamide—Nausea—Galantamine—Alzheimer's disease	0.000234	0.00134	CcSEcCtD
Dorzolamide—Fatigue—Rivastigmine—Alzheimer's disease	0.000233	0.00134	CcSEcCtD
Dorzolamide—CA2—brain—Alzheimer's disease	0.000232	0.0123	CbGeAlD
Dorzolamide—Pain—Rivastigmine—Alzheimer's disease	0.000232	0.00133	CcSEcCtD
Dorzolamide—Feeling abnormal—Memantine—Alzheimer's disease	0.000228	0.00131	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000226	0.0013	CcSEcCtD
Dorzolamide—Hypersensitivity—Donepezil—Alzheimer's disease	0.000225	0.00129	CcSEcCtD
Dorzolamide—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000223	0.00128	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000221	0.00127	CcSEcCtD
Dorzolamide—Urticaria—Memantine—Alzheimer's disease	0.00022	0.00126	CcSEcCtD
Dorzolamide—Body temperature increased—Memantine—Alzheimer's disease	0.000219	0.00126	CcSEcCtD
Dorzolamide—Abdominal pain—Memantine—Alzheimer's disease	0.000219	0.00126	CcSEcCtD
Dorzolamide—Asthenia—Donepezil—Alzheimer's disease	0.000219	0.00126	CcSEcCtD
Dorzolamide—Pruritus—Donepezil—Alzheimer's disease	0.000216	0.00124	CcSEcCtD
Dorzolamide—Urticaria—Rivastigmine—Alzheimer's disease	0.000215	0.00124	CcSEcCtD
Dorzolamide—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000214	0.00123	CcSEcCtD
Dorzolamide—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000214	0.00123	CcSEcCtD
Dorzolamide—Diarrhoea—Donepezil—Alzheimer's disease	0.000209	0.0012	CcSEcCtD
Dorzolamide—Hypersensitivity—Memantine—Alzheimer's disease	0.000204	0.00117	CcSEcCtD
Dorzolamide—Dizziness—Donepezil—Alzheimer's disease	0.000202	0.00116	CcSEcCtD
Dorzolamide—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.0002	0.00115	CcSEcCtD
Dorzolamide—Asthenia—Memantine—Alzheimer's disease	0.000199	0.00114	CcSEcCtD
Dorzolamide—Pruritus—Memantine—Alzheimer's disease	0.000196	0.00113	CcSEcCtD
Dorzolamide—CYP3A4—nervous system—Alzheimer's disease	0.000196	0.0104	CbGeAlD
Dorzolamide—Asthenia—Rivastigmine—Alzheimer's disease	0.000194	0.00112	CcSEcCtD
Dorzolamide—Vomiting—Donepezil—Alzheimer's disease	0.000194	0.00111	CcSEcCtD
Dorzolamide—Rash—Donepezil—Alzheimer's disease	0.000192	0.00111	CcSEcCtD
Dorzolamide—Dermatitis—Donepezil—Alzheimer's disease	0.000192	0.0011	CcSEcCtD
Dorzolamide—Pruritus—Rivastigmine—Alzheimer's disease	0.000192	0.0011	CcSEcCtD
Dorzolamide—Headache—Donepezil—Alzheimer's disease	0.000191	0.0011	CcSEcCtD
Dorzolamide—Diarrhoea—Memantine—Alzheimer's disease	0.000189	0.00109	CcSEcCtD
Dorzolamide—CYP3A4—central nervous system—Alzheimer's disease	0.000188	0.01	CbGeAlD
Dorzolamide—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000185	0.00107	CcSEcCtD
Dorzolamide—Dizziness—Memantine—Alzheimer's disease	0.000183	0.00105	CcSEcCtD
Dorzolamide—Nausea—Donepezil—Alzheimer's disease	0.000181	0.00104	CcSEcCtD
Dorzolamide—Dizziness—Rivastigmine—Alzheimer's disease	0.000179	0.00103	CcSEcCtD
Dorzolamide—Vomiting—Memantine—Alzheimer's disease	0.000176	0.00101	CcSEcCtD
Dorzolamide—Rash—Memantine—Alzheimer's disease	0.000175	0.001	CcSEcCtD
Dorzolamide—Dermatitis—Memantine—Alzheimer's disease	0.000174	0.001	CcSEcCtD
Dorzolamide—Headache—Memantine—Alzheimer's disease	0.000173	0.000997	CcSEcCtD
Dorzolamide—Vomiting—Rivastigmine—Alzheimer's disease	0.000172	0.00099	CcSEcCtD
Dorzolamide—Rash—Rivastigmine—Alzheimer's disease	0.000171	0.000982	CcSEcCtD
Dorzolamide—Dermatitis—Rivastigmine—Alzheimer's disease	0.000171	0.000981	CcSEcCtD
Dorzolamide—Headache—Rivastigmine—Alzheimer's disease	0.00017	0.000975	CcSEcCtD
Dorzolamide—Nausea—Memantine—Alzheimer's disease	0.000164	0.000945	CcSEcCtD
Dorzolamide—Nausea—Rivastigmine—Alzheimer's disease	0.000161	0.000925	CcSEcCtD
Dorzolamide—CA5B—Metabolism—ABCA1—Alzheimer's disease	3.97e-05	0.000431	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—A2M—Alzheimer's disease	3.89e-05	0.000422	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CHAT—Alzheimer's disease	3.84e-05	0.000417	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—TPI1—Alzheimer's disease	3.84e-05	0.000417	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	3.83e-05	0.000416	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PLCB1—Alzheimer's disease	3.8e-05	0.000412	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—MAPK8—Alzheimer's disease	3.79e-05	0.000411	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PPARGC1A—Alzheimer's disease	3.76e-05	0.000408	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—HMOX1—Alzheimer's disease	3.75e-05	0.000407	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ACHE—Alzheimer's disease	3.68e-05	0.0004	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—ABCA1—Alzheimer's disease	3.68e-05	0.000399	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—MAOB—Alzheimer's disease	3.68e-05	0.000399	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PPARGC1A—Alzheimer's disease	3.67e-05	0.000398	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PPARGC1A—Alzheimer's disease	3.67e-05	0.000398	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—HMOX1—Alzheimer's disease	3.65e-05	0.000396	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—HMOX1—Alzheimer's disease	3.65e-05	0.000396	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—INPP5D—Alzheimer's disease	3.64e-05	0.000395	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	3.62e-05	0.000393	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GAPDH—Alzheimer's disease	3.54e-05	0.000384	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	3.54e-05	0.000384	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ACHE—Alzheimer's disease	3.53e-05	0.000383	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—VEGFA—Alzheimer's disease	3.5e-05	0.000379	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—INPP5D—Alzheimer's disease	3.49e-05	0.000379	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ENO1—Alzheimer's disease	3.45e-05	0.000375	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PTGS1—Alzheimer's disease	3.45e-05	0.000375	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—LPL—Alzheimer's disease	3.43e-05	0.000372	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PPARGC1A—Alzheimer's disease	3.42e-05	0.000372	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PPARGC1A—Alzheimer's disease	3.42e-05	0.000372	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—A2M—Alzheimer's disease	3.42e-05	0.000371	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—HMOX1—Alzheimer's disease	3.41e-05	0.00037	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—HMOX1—Alzheimer's disease	3.41e-05	0.00037	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ACHE—Alzheimer's disease	3.39e-05	0.000367	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CYP2D6—Alzheimer's disease	3.39e-05	0.000367	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—INPP5D—Alzheimer's disease	3.35e-05	0.000363	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—LPL—Alzheimer's disease	3.34e-05	0.000362	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—LPL—Alzheimer's disease	3.34e-05	0.000362	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PTGS1—Alzheimer's disease	3.31e-05	0.000359	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ENO1—Alzheimer's disease	3.31e-05	0.000359	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CYP2D6—Alzheimer's disease	3.25e-05	0.000352	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—BCHE—Alzheimer's disease	3.21e-05	0.000348	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PTGS1—Alzheimer's disease	3.17e-05	0.000344	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ENO1—Alzheimer's disease	3.17e-05	0.000344	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PPARGC1A—Alzheimer's disease	3.17e-05	0.000344	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—HMOX1—Alzheimer's disease	3.16e-05	0.000343	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—LPL—Alzheimer's disease	3.12e-05	0.000338	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—LPL—Alzheimer's disease	3.12e-05	0.000338	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CYP2D6—Alzheimer's disease	3.11e-05	0.000338	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—MTHFR—Alzheimer's disease	3.09e-05	0.000335	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—BCHE—Alzheimer's disease	3.08e-05	0.000334	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PLCB1—Alzheimer's disease	3.03e-05	0.000329	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—MTHFR—Alzheimer's disease	3.01e-05	0.000326	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—MTHFR—Alzheimer's disease	3.01e-05	0.000326	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ACHE—Alzheimer's disease	2.98e-05	0.000323	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—BCHE—Alzheimer's disease	2.95e-05	0.00032	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—INPP5D—Alzheimer's disease	2.94e-05	0.000319	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ABCA1—Alzheimer's disease	2.94e-05	0.000318	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PLCB1—Alzheimer's disease	2.9e-05	0.000315	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—LPL—Alzheimer's disease	2.89e-05	0.000313	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—CALM1—Alzheimer's disease	2.88e-05	0.000313	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—APOE—Alzheimer's disease	2.87e-05	0.000312	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—CAV1—Alzheimer's disease	2.85e-05	0.000309	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ABCA1—Alzheimer's disease	2.81e-05	0.000305	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—CALM1—Alzheimer's disease	2.81e-05	0.000305	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—CALM1—Alzheimer's disease	2.81e-05	0.000305	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—MTHFR—Alzheimer's disease	2.81e-05	0.000305	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—MTHFR—Alzheimer's disease	2.81e-05	0.000305	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—APOE—Alzheimer's disease	2.8e-05	0.000304	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—APOE—Alzheimer's disease	2.8e-05	0.000304	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ENO1—Alzheimer's disease	2.79e-05	0.000303	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PTGS1—Alzheimer's disease	2.79e-05	0.000303	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PLCB1—Alzheimer's disease	2.78e-05	0.000302	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—CAV1—Alzheimer's disease	2.77e-05	0.000301	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—CAV1—Alzheimer's disease	2.77e-05	0.000301	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	2.75e-05	0.000298	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CYP2D6—Alzheimer's disease	2.74e-05	0.000297	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ABCA1—Alzheimer's disease	2.7e-05	0.000293	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	2.69e-05	0.000292	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	2.66e-05	0.000288	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—TP53—Alzheimer's disease	2.64e-05	0.000287	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—CALM1—Alzheimer's disease	2.62e-05	0.000285	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—CALM1—Alzheimer's disease	2.62e-05	0.000285	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—APOE—Alzheimer's disease	2.61e-05	0.000284	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—APOE—Alzheimer's disease	2.61e-05	0.000284	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—MTHFR—Alzheimer's disease	2.6e-05	0.000282	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—BCHE—Alzheimer's disease	2.59e-05	0.000281	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—CAV1—Alzheimer's disease	2.59e-05	0.000281	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—CAV1—Alzheimer's disease	2.59e-05	0.000281	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PPARGC1A—Alzheimer's disease	2.53e-05	0.000274	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—HMOX1—Alzheimer's disease	2.52e-05	0.000273	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PPARG—Alzheimer's disease	2.5e-05	0.000271	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—INS—Alzheimer's disease	2.45e-05	0.000266	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PLCB1—Alzheimer's disease	2.45e-05	0.000265	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PPARG—Alzheimer's disease	2.44e-05	0.000265	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PPARG—Alzheimer's disease	2.44e-05	0.000265	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—CALM1—Alzheimer's disease	2.43e-05	0.000264	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PPARGC1A—Alzheimer's disease	2.43e-05	0.000263	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—APOE—Alzheimer's disease	2.42e-05	0.000263	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—IL6—Alzheimer's disease	2.42e-05	0.000262	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—HMOX1—Alzheimer's disease	2.41e-05	0.000262	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—CAV1—Alzheimer's disease	2.4e-05	0.00026	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—INS—Alzheimer's disease	2.39e-05	0.000259	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—INS—Alzheimer's disease	2.39e-05	0.000259	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ABCA1—Alzheimer's disease	2.37e-05	0.000257	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	2.36e-05	0.000256	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PPARGC1A—Alzheimer's disease	2.33e-05	0.000252	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—HMOX1—Alzheimer's disease	2.32e-05	0.000251	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—LPL—Alzheimer's disease	2.3e-05	0.00025	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PPARG—Alzheimer's disease	2.28e-05	0.000247	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PPARG—Alzheimer's disease	2.28e-05	0.000247	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—INS—Alzheimer's disease	2.23e-05	0.000242	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—INS—Alzheimer's disease	2.23e-05	0.000242	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—LPL—Alzheimer's disease	2.21e-05	0.00024	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.2e-05	0.000239	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—NOS3—Alzheimer's disease	2.15e-05	0.000233	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—LPL—Alzheimer's disease	2.12e-05	0.00023	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PPARG—Alzheimer's disease	2.11e-05	0.000229	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—NOS3—Alzheimer's disease	2.1e-05	0.000228	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—NOS3—Alzheimer's disease	2.1e-05	0.000228	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—MTHFR—Alzheimer's disease	2.07e-05	0.000225	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—INS—Alzheimer's disease	2.07e-05	0.000224	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PPARGC1A—Alzheimer's disease	2.04e-05	0.000222	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—HMOX1—Alzheimer's disease	2.04e-05	0.000221	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CA4—Alzheimer's disease	2.01e-05	0.000218	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—MTHFR—Alzheimer's disease	1.99e-05	0.000216	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PTGS2—Alzheimer's disease	1.97e-05	0.000214	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	1.96e-05	0.000213	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—NOS3—Alzheimer's disease	1.96e-05	0.000212	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—NOS3—Alzheimer's disease	1.96e-05	0.000212	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CALM1—Alzheimer's disease	1.94e-05	0.00021	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—APOE—Alzheimer's disease	1.93e-05	0.000209	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PTGS2—Alzheimer's disease	1.92e-05	0.000208	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PTGS2—Alzheimer's disease	1.92e-05	0.000208	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CAV1—Alzheimer's disease	1.91e-05	0.000208	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—MTHFR—Alzheimer's disease	1.91e-05	0.000207	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	1.89e-05	0.000205	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—LPL—Alzheimer's disease	1.86e-05	0.000202	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CALM1—Alzheimer's disease	1.86e-05	0.000202	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—APOE—Alzheimer's disease	1.85e-05	0.000201	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CAV1—Alzheimer's disease	1.83e-05	0.000199	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—NOS3—Alzheimer's disease	1.81e-05	0.000197	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PTGS2—Alzheimer's disease	1.79e-05	0.000194	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PTGS2—Alzheimer's disease	1.79e-05	0.000194	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	1.79e-05	0.000194	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CALM1—Alzheimer's disease	1.78e-05	0.000193	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—APOE—Alzheimer's disease	1.77e-05	0.000193	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CAV1—Alzheimer's disease	1.76e-05	0.000191	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PLD3—Alzheimer's disease	1.71e-05	0.000185	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	1.71e-05	0.000185	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	1.69e-05	0.000183	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PPARG—Alzheimer's disease	1.68e-05	0.000182	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—MTHFR—Alzheimer's disease	1.68e-05	0.000182	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PTGS2—Alzheimer's disease	1.66e-05	0.00018	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—INS—Alzheimer's disease	1.65e-05	0.000179	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	1.64e-05	0.000177	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PPARG—Alzheimer's disease	1.61e-05	0.000175	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.6e-05	0.000173	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—INS—Alzheimer's disease	1.58e-05	0.000172	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	1.57e-05	0.000171	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CALM1—Alzheimer's disease	1.57e-05	0.00017	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—APOE—Alzheimer's disease	1.56e-05	0.000169	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	1.56e-05	0.000169	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CAV1—Alzheimer's disease	1.55e-05	0.000168	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PPARG—Alzheimer's disease	1.55e-05	0.000168	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ND1—Alzheimer's disease	1.52e-05	0.000165	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—INS—Alzheimer's disease	1.52e-05	0.000164	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.49e-05	0.000161	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—NOS3—Alzheimer's disease	1.45e-05	0.000157	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—NOS3—Alzheimer's disease	1.39e-05	0.00015	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.36e-05	0.000147	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PPARG—Alzheimer's disease	1.36e-05	0.000147	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—INS—Alzheimer's disease	1.33e-05	0.000145	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—NOS3—Alzheimer's disease	1.33e-05	0.000144	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.32e-05	0.000144	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PTGS2—Alzheimer's disease	1.32e-05	0.000144	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PTGS2—Alzheimer's disease	1.27e-05	0.000138	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.24e-05	0.000135	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PTGS2—Alzheimer's disease	1.22e-05	0.000132	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.18e-05	0.000128	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.17e-05	0.000127	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—NOS3—Alzheimer's disease	1.17e-05	0.000127	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.13e-05	0.000122	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.08e-05	0.000117	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PTGS2—Alzheimer's disease	1.07e-05	0.000116	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.07e-05	0.000116	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.04e-05	0.000113	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ND1—Alzheimer's disease	1e-05	0.000109	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—AKT1—Alzheimer's disease	9.89e-06	0.000107	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—TPI1—Alzheimer's disease	9.8e-06	0.000106	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CHAT—Alzheimer's disease	9.8e-06	0.000106	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—AKT1—Alzheimer's disease	9.64e-06	0.000105	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—AKT1—Alzheimer's disease	9.64e-06	0.000105	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—MAOB—Alzheimer's disease	9.4e-06	0.000102	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	9.05e-06	9.81e-05	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—AKT1—Alzheimer's disease	9e-06	9.76e-05	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—AKT1—Alzheimer's disease	9e-06	9.76e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	8.94e-06	9.7e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	8.86e-06	9.61e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—A2M—Alzheimer's disease	8.74e-06	9.48e-05	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—AKT1—Alzheimer's disease	8.34e-06	9.05e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	7.79e-06	8.45e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ACHE—Alzheimer's disease	7.6e-06	8.24e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	7.51e-06	8.15e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ENO1—Alzheimer's disease	7.12e-06	7.73e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	7.12e-06	7.73e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	6.98e-06	7.58e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—AKT1—Alzheimer's disease	6.65e-06	7.21e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—BCHE—Alzheimer's disease	6.62e-06	7.18e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—TPI1—Alzheimer's disease	6.46e-06	7.01e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CHAT—Alzheimer's disease	6.46e-06	7.01e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—AKT1—Alzheimer's disease	6.38e-06	6.92e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	6.25e-06	6.78e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—MAOB—Alzheimer's disease	6.2e-06	6.72e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.13e-06	6.65e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—AKT1—Alzheimer's disease	6.11e-06	6.63e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	6.06e-06	6.57e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	5.97e-06	6.47e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—A2M—Alzheimer's disease	5.76e-06	6.25e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—AKT1—Alzheimer's disease	5.37e-06	5.83e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	5.22e-06	5.66e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	5.2e-06	5.64e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ACHE—Alzheimer's disease	5.01e-06	5.44e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	4.95e-06	5.37e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—LPL—Alzheimer's disease	4.75e-06	5.15e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	4.7e-06	5.09e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ENO1—Alzheimer's disease	4.7e-06	5.09e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	4.61e-06	5e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—BCHE—Alzheimer's disease	4.37e-06	4.74e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	4.28e-06	4.64e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	4.12e-06	4.47e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CALM1—Alzheimer's disease	4e-06	4.34e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	3.99e-06	4.33e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—APOE—Alzheimer's disease	3.98e-06	4.32e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CAV1—Alzheimer's disease	3.95e-06	4.28e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PPARG—Alzheimer's disease	3.47e-06	3.76e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	3.44e-06	3.73e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	3.43e-06	3.72e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—INS—Alzheimer's disease	3.4e-06	3.69e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—LPL—Alzheimer's disease	3.13e-06	3.4e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NOS3—Alzheimer's disease	2.98e-06	3.24e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.82e-06	3.06e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	2.73e-06	2.96e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.64e-06	2.86e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.63e-06	2.85e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.6e-06	2.82e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.29e-06	2.48e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—INS—Alzheimer's disease	2.24e-06	2.43e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.97e-06	2.13e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.8e-06	1.95e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.37e-06	1.49e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AKT1—Alzheimer's disease	9.05e-07	9.81e-06	CbGpPWpGaD
